pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Mar 2, 2026

    11
    ›Mar 6, 2026grant178d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — Low-dose naltrexone (LDN) for the treatment of Myalgic Encephalomyelitis/Chro...Aardvark Therapeutics, Inc.

    NS grant. $556,686. PI: Jarred W. Younger

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoALBANY MEDICAL COLLEGE — Modulating the Hippo pathway in Charcot-Marie-Tooth disease

    NS grant. $562,051. PI: SOPHIE BELIN

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoBAYLOR COLLEGE OF MEDICINE — Elucidating the role of translational control in hematopoietic stem cell quie...Baylor College of Medicine

    HL grant. $49,866. PI: Caroline Sands

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoUNIVERSITY OF WASHINGTON — Development of an immunocompetent colon chip to model Crohn's DiseaseUniversity of Washington

    DK grant. $825,905. PI: Nancy L. Allbritton

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoGORDON RESEARCH CONFERENCES — 2026 Craniofacial Morphogenesis and Tissue Regeneration Gordon Research Confe...

    DE grant. $23,000. PI: Samantha A Brugmann

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoUNIVERSITY OF OREGON — Responsive and Targeted Modulation of Reactive Sulfur Species

    GM grant. $398,464. PI: Michael Pluth

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoUNIVERSITY OF PENNSYLVANIA — Molecular determinants of voltage-gated ion channels' localization and functionUniversity of Pennsylvania

    GM grant. $446,875. PI: Natali L Chanaday Ricagni

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — Regulation of ER-phagy during cellular stresses

    GM grant. $429,000. PI: Yang Liu

    full page →nih reporter ↗
    ›Mar 6, 2026grant178d agoSTANFORD UNIVERSITY — Dissecting the molecular mechanisms of membrane protein complex assemblyStanford University

    GM grant. $423,500. PI: Tino Pleiner

    full page →nih reporter ↗
    ›Mar 7, 2026grant177d agoUNIVERSITY OF WASHINGTON — Population Genomics Screening Network (PGSN) Coordinating CenterUniversity of Washington

    HG grant. $2,114,800. PI: Kenneth M. Rice

    full page →nih reporter ↗
    ›Mar 7, 2026grant177d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — Exploiting RNA biogenesis to accelerate neuronal maturation and model age-rel...

    NS grant. $126,900. PI: Brian Jude Joseph

    full page →nih reporter ↗

    Week of Mar 9, 2026

    39
    ›Mar 9, 2026approval175d agoOXCARBAZEPINE — FDA approvalRiconpharma LLC

    Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026approval
    ← prev
    page 445 of 475
    next →
    175d ago
    ATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Mar 9, 2026approval175d agoBISOPROLOL FUMARATE — FDA approvalBISOPROLOL FUMARATE

    Sponsor: MICRO LABS. Form: TABLET. Route: ORAL

    full page →BISOPROLOL FUMARATE →fda approvals ↗
    ›Mar 9, 2026approval175d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

    Sponsor: B BRAUN. Form: SOLUTION. Route: IRRIGATION

    full page →fda approvals ↗
    ›Mar 9, 2026approval175d agoFAMOTIDINE — FDA approvalKenvue Inc.

    Sponsor: CONTRACT PHARMACAL. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026approval175d agoIVERMECTIN — FDA approvalMedinCell SA

    Sponsor: E5 PHARMA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026approval175d agoWELLCOVORIN (LEUCOVORIN CALCIUM) — FDA approvalLEUCOVORIN CALCIUM

    Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL

    full page →LEUCOVORIN CALCIUM →fda approvals ↗
    ›Mar 9, 2026approval175d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

    Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION

    full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 9, 2026approval175d agoQUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: NEXTWAVE. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 9, 2026grant175d agoUNIVERSITY OF MISSOURI KANSAS CITY — Gene-regulatory mechanisms of neuronal circuit formation in Drosophila

    NS grant. $137,687. PI: Jelly Hubertus Maria Soffers

    full page →nih reporter ↗
    ›Mar 9, 2026grant175d agoPENNSYLVANIA STATE UNIVERSITY, THE — Evolving together, evolving apart: probing the genomic basis of a facultative...

    GM grant. $393,250. PI: Liana Twardosz Burghardt

    full page →nih reporter ↗
    ›Mar 9, 2026grant175d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — A Program Investigating New Concepts ofMacrophage Biology in Atherosclerosis ...

    HL grant. $1,151,500. PI: Ira A Tabas

    full page →nih reporter ↗
    ›Mar 9, 2026grant175d agoUNIVERSITY OF WASHINGTON — High-throughput and Machine Learning Optimization of Fluorescent Sensors for ...University of Washington

    MH grant. $2,305,031. PI: Andre Berndt

    full page →nih reporter ↗
    ›Mar 9, 2026grant175d agoUNIVERSITY OF CALIFORNIA BERKELEY — Site-specific Non-LTR Retrotransposon Mechanisms of Mobility and Transgene In...

    GM grant. $617,574. PI: Kathleen Collins

    full page →nih reporter ↗
    ›Mar 9, 2026grant175d agoUNIVERSITY OF GEORGIA — Role of CTCF in Nucleotide Excision Repair

    GM grant. $300,872. PI: Wentao Li

    full page →nih reporter ↗
    ›Mar 10, 2026approval174d agoKARBINAL ER (CARBINOXAMINE MALEATE) — FDA approvalAYTU BIOPHARMA, INC

    Sponsor: AYTU. Form: SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 10, 2026approval174d agoARCALYST (RILONACEPT) — FDA approvalrilonacept

    Sponsor: KINIKSA PHARMACEUTICALS (UK), LTD.. Form: VIAL. Route: SINGLE-USE

    full page →rilonacept →fda approvals ↗
    ›Mar 10, 2026approval174d agoQUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

    Sponsor: NEXTWAVE PHARMS. Form: TABLET, EXTENDED RELEASE, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 10, 2026approval174d agoDESVENLAFAXINE SUCCINATE — FDA approvaldesvenlafaxine succinate ER

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →desvenlafaxine succinate ER →fda approvals ↗
    ›Mar 10, 2026approval174d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: INNOGENIX. Form: TABLET. Route: ORAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Mar 10, 2026approval174d agoDOXIL (LIPOSOMAL) (DOXORUBICIN HYDROCHLORIDE) — FDA approvalDoxil

    Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →Doxil →fda approvals ↗
    ›Mar 10, 2026approval174d agoALEVE (NAPROXEN SODIUM) — FDA approvalNAPROXEN SODIUM

    Sponsor: BAYER. Form: TABLET. Route: ORAL

    full page →NAPROXEN SODIUM →fda approvals ↗
    ›Mar 10, 2026approval174d agoADAPALENE — FDA approvalPL Developments Copiague LLC

    Sponsor: P AND L. Form: GEL. Route: TOPICAL

    full page →fda approvals ↗
    ›Mar 10, 2026approval174d agoOGSIVEO (NIROGACESTAT HYDROBROMIDE) — FDA approvalnirogacestat hydrobromide

    Sponsor: SPRINGWORKS. Form: TABLET. Route: ORAL

    full page →nirogacestat hydrobromide →fda approvals ↗
    ›Mar 10, 2026approval174d agoMESALAMINE — FDA approvalDifGen Pharmaceuticals LLC

    Sponsor: DIFGEN PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF TENNESSEE HEALTH SCI CTR — Extended amygdala somatostatin role in post-traumatic stress and alcohol use ...

    AA grant. $249,000. PI: Bryan Cruz

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoBOSTON CHILDREN'S HOSPITAL — Developing Cognitive Control and Metacognition to Reduce the Functional Impac...Boston Children's Hospital

    MH grant. $990,550. PI: Susan Faja

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Transgenic Access to Semilunar Granule of the Dentate Gyrus

    MH grant. $431,750. PI: Michael Roland Williams

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoBRIGHAM AND WOMEN'S HOSPITAL — Using genomic modifiers to mechanistically link clonal hematopoiesis of indet...Brigham and Women's Hospital

    HL grant. $249,000. PI: Tetsushi Nakao

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoNEW YORK UNIVERSITY — Data-driven modeling of molecular mechanisms underlying cellular quiescenceNew York University

    GM grant. $421,737. PI: Sarah Kostinski

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Molecular and functional dissection of prefrontal-hippocampal long-range inhi...University of California San Francisco

    MH grant. $800,384. PI: Vikaas Singh Sohal

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Predicting Pediatric Postoperative Complications using Waveform and Electroni...University of California Los Angeles

    EB grant. $174,861. PI: Theodora E Wingert

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoDANA-FARBER CANCER INST — Elucidating the Origins and Drivers of Clonal Dynamics in Hematopoiesis

    HL grant. $445,000. PI: Sahand Hormoz

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Complement resistance and acute lung injury during Klebsiella pneumoniae infe...

    HL grant. $53,507. PI: Nathalie Chen

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoWEILL MEDICAL COLL OF CORNELL UNIV — AlphaFold-Assisted Affinity Probe Resource for Scalable Brain Protein Mapping...

    MH grant. $1,611,088. PI: Zhuhao Wu

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF WISCONSIN-MADISON — Revealing the role of vimentin in adult mouse hippocampal neurogenesis

    NS grant. $415,717. PI: Darcie Leann Moore

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF PENNSYLVANIA — Molecular Timekeepers: Converging Pathways in Circadian ControlUniversity of Pennsylvania

    GM grant. $487,287. PI: Akhilesh Basi Reddy

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF DELAWARE — Modules to improve the quality of the mentor-mentee working relationship

    GM grant. $94,154. PI: Lisa Jaremka

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoYALE UNIVERSITY — Regulation of infant social behaviors and learning by the zona incerta

    MH grant. $838,378. PI: Marcelo Dietrich

    full page →nih reporter ↗
    $AARD5.7900-12.54%
    $AYTU2.2300-0.89%
    $COLL25.35-4.12%
    $KVUE19.17-0.16%
    $COLL25.35-4.12%